“Year of the Future”

“Year of the Future”

December 1, 2020 Virtual Meeting

Antitrust StatementThe Joint Commission of Pharmacy Practitioners (JCPP) complies with all Federal and State Antitrust laws, rules and

regulations. Therefore:

1) These policies and procedures apply to all membership, board, committee and other meetings of JCPP, and all meetings

attended by representatives of JCPP.

2) Meetings will follow a formal, pre-approved agenda which will be provided to each attendee. Participants at meetings

should adhere strictly to the agenda. Subjects not included on the agenda should generally not be considered at the meeting.

3) The agenda will be specific and will prohibit discussions or recommendations regarding topics that may cause antitrust

problems, such as prices or price levels. In addition, no discussion is permitted of any elements of a company's operations which

might influence price such as:

a) Cost of operations, supplies, labor or services;

b) Allowance for discounts;

c) Terms of sale including credit arrangements; and,

d) Profit margins and mark ups, provided this limitation shall not extend to discussions of methods of operation, maintenance, and

similar matters in which cost or efficiency is merely incidental.

4) It is a violation of Antitrust laws to agree not to compete, therefore, discussions of division of territories or customers or

limitations on the nature of business carried on or products sold are not permitted.

5) Boycotts in any form are unlawful. Discussion relating to boycotts is prohibited, including discussions about blacklisting or

unfavorable reports about particular companies including their financial situation.

6) Where there is a potential for discussion of legally sensitive subjects, legal counsel may attend the meeting. Whenever

discussion borders on an area of antitrust sensitivity, JCPP members and/or representatives should request that the discussion be stopped and

ask that the request be made a part of the minutes of the meeting being attended. If others continue such discussion, the JCPP members and/or

representatives should excuse themselves from the meeting and request that the minutes show that the representative(s) left the meeting at

that point and why the representative(s) left. Any such instances should be reported immediately to the JCPP Secretary.

7) All meeting summaries should be kept that accurately report what actions, if any, were taken.

8) Unscheduled, informal, or secret meetings related to the above activities held in conjunction with the regular meetings should be

avoided. These meetings jeopardize legitimate activities and create a substantial risk of investigation.

9) Members should check with JCPP staff and/or their own counsel if there is any doubt about the propriety of a JCPP program or

subject of discussion.

(MEETING LOCATION : VIRTUAL / SEPT: SHERATON SUITES OLD TOWN HOTEL

– REGISTRATION AT JCCP.NET

2021 Meeting Dates

Meeting Date

February 2, 2021 – VIRTUAL Chair: Bartlemay (ACA)https://jcpp.net/event/jcpp-february-2-2021-meeting-virtual/May 5, 2021 – VIRTUAL Chair: Maddux (ACCP)September 30, 2021 – LIVE Chair: Knoer (APhA)

https://jcpp.net/event/jcpp-february-2-2021-meeting-virtual/

“Looking at the Future through the COVID lens”

Agenda

10:00am-10:15am Agenda Item 1: Welcome and Intros10:15am – 11:00am Agenda Item 2: “Recent elections and projected impact on pharmacy

issues”11:00am – 11:45am Agenda item 3: “RAPID Alliance Update and Strategies for Advancing

Work of Profession”11:45am – 12:15pm Lunch Break12:15pm – 1:00pm Agenda Item 4: “GTMRx Update and How Its Work Aligns to JCPP’s

Focus”1:00pm – 2:15pm Agenda Item 5: Discussion on Strategic Framework to Advance

Pharmacy Practice- Vision- Focus Areas- Winter meeting discussion

2:15pm Adjourn

“Recent elections and projected impact on pharmacy issues”

• December 1, 2020

• 10:15am – 11:00am

Recent Elections – Projected Impact on Pharmacy

JCPP MeetingDecember 1, 2020

Federal Elections

Alicia Kerry J. Mica – APhA

Adam Harbison – NCPA

Recap of the Midterm Elections – Impact on Pharmacy

Government Affairs Staff

117th U.S. House of Representatives

222 205

as of 11.25.2020

New House Members in the 117th Congress (1 of 2)

Jerry Carl (R-AL-1) ** Marie Newman (D-IL-3) Ritchie Torres (D-NY-15)

Barry Moore (R-AL-2) Mary Miller (R-IL-15) Jamaal Bowman (D-NY-16)

Jay Obernolte (R-CA-2 Ashley Hinson (R-IA-1) Mondaire Jones (D-NY-17)

Young Kim (R-CA-39) Randy Feenstra (R-IA Deborah Ross (D-NC-2)

Michelle Steel (R-CA-48) Frank Mrvan (D-IN-1) Kathy Manning (D-NC-6)

Darrell Issa (R-CA-50) Victoria Spartz (R-IN-5) Madison Cawthorn (R-NC-11_

Sara Jacobs (D-CA-53) Tracey Mann (R-KS-1) Stephanie Bice (R-OK-5)

Lauren Boebert (R-CO-3) Jake LaTurner (R-KS-2) Cliff Bentz (R-OR-2)

Kat Cammack (R-FL-3) Jake Auchincloss (D-MA-4) Nancy Mace (R-SC-1)

Scott Franklin (R-FL-15) Peter Meijer (R-MI-3) Diana Harshbarger (R-TN-1) **

Byron Donalds (R-FL-19) Lisa McClain (R-MI-10) Pat Fallon (R-TX-4)

Carlos Gimenez (R-FL-26) Michelle Fischbach (R-MN-7) August Pfluger (R-TX-11)

Maria Elvira Salazar (R-FL-27) Cori Bush (D-MO-1) Ronny Jackson (R-TX-13)

Nikema Williams (D-GA-5) Matt Rosendale (R-MT-AL) Pete Sessions (R-TX-17)

Carolyn Bordeaux (D-GA-7) Yvette Herrell (R-NM-2) Troy Nehls (R-TX-22)

Andrew Clyde (R-GA-9) Teresa Leger Fernandez (D-NM-3) Tony Gonzalez (R-TX-23)

Marjorie Taylor Greene (R-GA-14) Nicole Malliotakis (R-NY-11) Beth Van Duyne (R-TX-24)

Kai Kahele (D-HI-2) Chris Pappas (D-NH-01) Blake Moore (R-UT-1)

New House Members in the 117th Congress (2 of 2)

Burgess Owens (R-UT-4)

Bob Good (R-VA-5)

Marilyn Strickland (D-WA-10)

Scott Fitzgerald (R-WI-5)

Party Control of

This Seat

Biography

BIRTH DATE

Unknown

EDUCATION

Attended, Forestry, Lake City

Community College

FAMILY

Wife: Tina; 3 Children

116TH 117TH

R R

District Profile

COOK PVI 2020 VOTE

RATING

R+15 Solid R

Election Results

2020 GENERAL

Carl 65%

Averhart 35%

Background

A business-savvy entrepreneur who currently serves as a Mobile County Commissioner, Carl ran to represent a

solidly Republican Alabaman district in the House; pledges allegiance to President Trump and supports

conservative policies including ensuring gun rights, preventing tax increases, and implementing restrictive

immigration policies

A Mobile native, Carl left college in 1978 to enter the workforce and a couple of years later, founded the first of

his many businesses, Stat Medical; expanded the company to seven different locations and sold it to Rotech

Medical, where he served as a regional manager

Established multiple companies, including management groups, development associations, pharmacy services,

and an organization dedicated to buying and selling timberlands

In 2012, he launched his largely self-financed campaign for County Commission after becoming bothered by the

lack of employment opportunities in Mobile, an economy that led his son to reenlist in the Marines; opposed a

tolling initiative to pay for the Mobile River Bridge and Bayway Project and worked to invest settlement money

from the 2010 BP oil spill into infrastructure projects

Defeated former state Senator Bill Hightower (R) in the 2020 Republican Primary by over four percentage points;

Carl’s campaign ads criticized Hightower of affiliating with “Never Trumpers” and claimed he supported higher

taxes

Conservative platform protects gun rights, opposes criminalizing private firearm transfers between friends and

family members, and supports national concealed carry reciprocity; adamantly opposes any federal funding of

Planned Parenthood and pledges to support pro-life legislation

Immigration agenda seeks to fully fund the border wall and Immigration and Customs Enforcement, and vocally

opposes establishing sanctuary cities in Alabama; opposes a pathway to citizenship for undocumented

individuals and seeks to establish minimum sentencing requirements for crossing the border without proper legal

status

Promotes instituting a flat tax and a balanced budget amendment, suggesting that congressional members

should forfeit their pay if Congress doesn’t pass a balanced budget on time

Jerry Carl (AL-1)

S O U R C E Associated Press; Vignette, by National Journal

A P D A T A A S O F 11/23/2020 8:01 AM

R

Party Control of

This Seat

Biography

BIRTH DATE

Unknown

EDUCATION

Unknown

FAMILY

Unknown

116TH 117TH

R R

District Profile

COOK PVI 2020 VOTE

RATING

R+28 Solid R

Election Results

2020 GENERAL

Harshbarger 75%

Walsingham 22%

Background

A pharmacist and Sunday school teacher representing a heavily conservative constituency in Northeastern

Tennessee

Born in Kingsport and raised in nearby Bloomingdale, spending her entire career in her district; Harshbarger was

a first generation college student and the first in her family to graduate from high school

Graduated from pharmacy school and returned to her district to build a pharmacy business

After Rep. Phil Roe (R-TN1) announced his retirement, Harshbarger joined more than a dozen Republicans in a

crowded GOP primary for a safe district; Harshbarger narrowly defeated a state senator and a state

representative in the 2020 primary, and easily won the general election by more that 50 points

Prioritizes choice in education policy, working to increase trade and technical skills so students can avoid debt

Opposes the Affordable Care Act (ACA) and seeks to make health care more affordable by increasing

transparency for generic drugs; has not published a detailed health platform but supports increased competition

in the health care market

Strongly advocates for religious freedom and pro-life policies

Diana Harshbarger (TN-1)

S O U R C E Associated Press; Vignette, by National Journal

A P D A T A A S O F 11/23/2020 8:01 AM

R

House Democratic Leadership

• Speaker: Nancy Pelosi (CA) (formerly voted January 3, 2021)

• Majority Leader: Steny Hoyer (MD)

• Majority Whip: Jim Clyburn (SC)

• Assistant Speaker: Katherine Clark (MA)

• Caucus Chair: Hakeem Jeffries (NY)

• Caucus Vice Chair: Pete Aguilar (CA)

House Republican Leadership

• Minority Leader: Kevin McCarthy (CA)

• Minority Whip: Steve Scalise (LA)

• Republican Conference Chair: Liz Cheney (WY)

• National Republican Congressional Committee Chair: Tom Emmer (MN)

• Republican Conference Vice Chair: Mike Johnson (LA)

• Republican Conference Secretary: Richard Hudson (NC)

• Republican Policy Committee Chair: Gary Palmer (AL)

16

Potential House Committee Leadership

Committee Democratic Leader Republican Leader

House Energy and Commerce (E&C) Frank Pallone (NJ)

Greg Walden (OR)(retiring)

Michael Burgess (TX) Bob Latta (OH)

Cathy McMorris Rodgers (WA)

House Ways and Means(W&M)

Richard Neal (MA) Kevin Brady (TX)

LAST UPDATED 11/19/2020

S O U R C E House Clerk; Associated Press

House Committee on Energy and Commerce

Won reelection

Not up for election

Lost election/retired

Not yet called

Democrats1. Frank Pallone, Jr. (NJ-6), Chair2. Bobby L. Rush (IL-1)3. Anna G. Eshoo (CA-18)4. Eliot L. Engel (NY-16)5. Diana DeGette (CO-1)6. Michael F. Doyle (PA-18)7. Janice D. Schakowsky (IL-9)8. G. K. Butterfield (NC-1)9. Doris O. Matsui (CA-6)10. Kathy Castor (FL-14)11. John P. Sarbanes (MD-3)12. Jerry McNerney (CA-9)13. Peter Welch (VT-AL)14. Ben Ray Luján (NM-3)15. Paul Tonko (NY-20)16. Yvette D. Clarke (NY-9), Vice Chair17. David Loebsack (IA-2)18. Kurt Schrader (OR-5)19. Joseph P. Kennedy III (MA-4)20. Tony Cárdenas (CA-29)21. Raul Ruiz (CA-36)22. Scott H. Peters (CA-52)23. Debbie Dingell (MI-12)24. Marc A. Veasey (TX-33)25. Ann M. Kuster (NH-2)26. Robin L. Kelly (IL-2)27. Nanette Diaz Barragán (CA-44)28. A. Donald McEachin (VA-4)29. Lisa Blunt Rochester (DE-AL)30. Darren Soto (FL-9)31. Tom O'Halleran (AZ-1)

Republicans1. Greg Walden (OR-2)2. Fred Upton (MI-6)3. John Shimkus (IL-15)4. Michael C. Burgess (TX-26)5. Steve Scalise (LA-1)6. Robert E. Latta (OH-5)7. Cathy McMorris Rodgers (WA-5)8. Brett Guthrie (KY-2)9. Pete Olson (TX-22)10. David B. McKinley (WV-1)11. Adam Kinzinger (IL-16)12. H. Morgan Griffith (VA-9)13. Gus M. Bilirakis (FL-12)14. Bill Johnson (OH-6)15. Billy Long (MO-7)16. Larry Bucshon (IN-8)17. Bill Flores (TX-17)18. Susan W. Brooks (IN-5)19. Markwayne Mullin (OK-2)20. Richard Hudson (NC-8)21. Tim Walberg (MI-7)22. Earl L. "Buddy" Carter (GA-1)23. Jeff Duncan (SC-3)24. Greg Gianforte (MT-AL)


S O U R C E House Clerk; Associated Press

House Committee on Ways and Means

Won reelection

Not up for election


Not yet called

Democrats Republicans

1. Richard E. Neal (MA-1), Chair 1. Kevin Brady (TX-8)

2. Lloyd Doggett (TX-35) 2. Devin Nunes (CA-22)

3. Mike Thompson (CA-5) 3. Vern Buchanan (FL-16)

4. John B. Larson (CT-1) 4. Adrian Smith (NE-3)

5. Earl Blumenauer (OR-3) 5. Kenny Marchant (TX-24)

6. Ron Kind (WI-3) 6. Tom Reed (NY-23)

7. Bill Pascrell, Jr. (NJ-9) 7. Mike Kelly (PA-16)

8. Danny K. Davis (IL-7) 8. George Holding (NC-2)

9. Linda T. Sánchez (CA-38) 9. Jason Smith (MO-8)

10. Brian Higgins (NY-26) 10. Tom Rice (SC-7)

11. Terri A. Sewell (AL-7) 11. David Schweikert (AZ-6)

12. Suzan K. DelBene (WA-1) 12. Jackie Walorski (IN-2)

13. Judy Chu (CA-27) 13. Darin LaHood (IL-18)

14. Gwen Moore (WI-4) 14. Brad R. Wenstrup (OH-2)

15. Daniel T. Kildee (MI-5) 15. Jodey C. Arrington (TX-19)

16. Brendan F. Boyle (PA-2) 16. A. Drew Ferguson IV (GA-3)

17. Donald S. Beyer, Jr. (VA-8) 17. Ron Estes (KS-4)

18. Dwight Evans (PA-3)

19. Bradley Scott Schneider (IL-10)

20. Thomas R. Suozzi (NY-3)

21. Jimmy Panetta (CA-20)

22. Stephanie N. Murphy (FL-7)

23. Jimmy Gomez (CA-34)

24. Steven Horsford (NV-4)

25. Cedric L. Richmond (LA-2)

117th U.S. Senate

5048

New Senators in the 117th Congress

Tommy Tubberville (R-AL)

Mark Kelly (D-AZ)

John Hickenlooper (D-CO)

Roger Marshall (R-KS)

Ben Ray Lujan (D-NM)

Bill Hagerty (R-TN)

Cynthia Lummis (R-WY)

Two runoffs in Georgia will decide Senate control

Candidate Votes Pct.

Warnock 1,616,228 32.9%

Loeffler* 1,272,198 25.9%

Collins 979,555 19.9%

Incumbent: Sen. Kelly Loeffler (R)

First appointed in 2020 to succeed Sen.

Isakson

Former businesswoman

Challenger: Rev. Raphael Warnock (D)

Pastor at Ebenezer Baptist Church

2020 jungle primary results

Candidate Votes Pct.

Perdue* 2,460,589 49.7%

Ossoff 2,373,440 48.0%

Incumbent: Sen. David Perdue (R)

First appointed in 2014

Former businessman

Challenger: Jon Ossoff (D), former

GA-6 special election candidate

2020 general election results

GA Class III Special Election

GA Class II General Election

S O U R C E Associated Press

A P D A T A A S O F 11/20/2020 8:26 AM

Senate Republican Leadership

• Senate Republican Leader: Mitch McConnell (KY)

• Republican Whip: John Thune (SD)

• Chair of Republican Conference: John Barrasso (WY)

• Policy Committee Chair: Roy Blunt (MO)

• Vice Chair Republican Conference: Joni Ernst (IA)

• Chair of the National Republican Senatorial Committee: Rick Scott (FL)

Senate Democratic Leadership

• Senate Democratic Leader and Chair of the Conference: Charles E. Schumer (NY)

• Democratic Whip: Richard J. Durbin (IL)

• Assistant Democratic Leader: Patty Murray (WA)

• Chair, Democratic Policy and Communications Committee: Debbie Stabenow (MI)

• Vice Chair, Democratic Conference: Elizabeth Warren (MA) and Mark Warner (VA)

• Chair, Steering Committee: Amy Klobuchar (MN)

• Chair, Outreach: Bernie Sanders (VT)

• Vice Chair, Democratic Policy and Communications Committee: Cory Booker (NJ) and Joe Manchin (WV)

• Secretary of Democratic Caucus: Tammy Baldwin (WI)

• Chair, Democratic Senatorial Campaign Committee: TBD – Schumer-appointed position

24

Potential Senate Committee Leadership

Committee Democratic Leader Republican Leader

Senate Health, Education, Labor & Pensions (HELP)

Patty Murray (WA) (Veterans’ Affairs)

Bernie Sanders (VT) (Budget)

Lamar Alexander (TN)(retiring/term limit)Richard Burr (NC)

Rand Paul (KY) (Small Business)

Senate Finance Ron Wyden (OR)

Chuck Grassley (IA) (term limit)

Mike Crapo (ID) (Budget or Banking)


S O U R C E Secretary of the Senate; Associated Press

Senate Committee on Finance

Won reelection

Not up for election


Not yet called

Republicans Democrats

1. Chuck Grassley (R-IA), Chairman 1. Ron Wyden (D-OR), Ranking

2. Mike Crapo (R-ID) 2. Debbie Stabenow (D-MI)

3. Pat Roberts (R-KS) 3. Maria Cantwell (D-WA)

4. Michael B. Enzi (R-WY) 4. Robert Menendez (D-NJ)

5. John Cornyn (R-TX) 5. Thomas R. Carper (D-DE)

6. John Thune (R-SD) 6. Benjamin L. Cardin (D-MD)

7. Richard Burr (R-NC) 7. Sherrod Brown (D-OH)

8. Rob Portman (R-OH) 8. Michael F. Bennet (D-CO)

9. Patrick J. Toomey (R-PA) 9. Robert P. Casey (D-PA)

10. Tim Scott (R-SC) 10. Mark R. Warner (D-VA)

11. Bill Cassidy (R-LA) 11. Sheldon Whitehouse (D-RI)

12. James Lankford (R-OK) 12. Margaret Wood Hassan (D-NH)

13. Steve Daines (R-MT) 13. Catherine Cortez Masto (D-NV)

14. Todd Young (R-IN)

15. Ben Sasse (R-NE)


S O U R C E Secretary of the Senate; Associated Press

Senate Committee on Health, Education, Labor, and Pensions

Won reelection

Not up for election


Not yet called

Republicans Democrats

1. Lamar Alexander (R-TN), Chairman 1. Patty Murray (D-WA), Ranking

2. Michael B. Enzi (R-WY) 2. Bernard Sanders (D-VT)

3. Richard Burr (R-NC) 3. Robert P. Casey (D-PA)

4. Rand Paul (R-KY) 4. Tammy Baldwin (D-WI)

5. Susan M. Collins (R-ME) 5. Christopher Murphy (D-CT)

6. Bill Cassidy (R-LA) 6. Elizabeth Warren (D-MA)

7. Pat Roberts (R-KS) 7. Tim Kaine (D-VA)

8. Lisa Murkowski (R-AK) 8. Margaret Wood Hassan (D-NH)

9. Tim Scott (R-SC) 9. Tina Smith (D-MN)

10. Mitt Romney (R-UT) 10. Doug Jones (D-AL)

11. Mike Braun (R-IN) 11. Jacky Rosen (D-NV)

12. Kelly Loeffler (R-GA)

What to expect…

“… the potential for near-total gridlock on the legislative front if the two sides can’t come together on things like coronavirus relief or infrastructure spending.” – Politico, 11/5/20

Dates to Know

12/11/20 Continuing Resolution to fun the federal government and certain extenders expire

12/14/20

12/31/20

1/3/21

1/20/21

The Electoral College meet in their respective states to cast their votes by paper ballot for President and Vice President.

COVID/CARES Act provisions expire

Members of the House and Senate are sworn into office for the 117th Session of Congress

Inauguration Day – President and Vice-President are sworn into office

Georgia Senate Runoffs Election1/6/21

State Results

Allie Jo Shipman, PharmD, MBA – NASPA

Pharmacists in State Legislatures

• 38 pharmacists in elected state office

• 26 states

• 28 Republicans, 10 Democrats

• Senators, Representatives/ Assemblymen/Delegates, State Auditor, Insurance Commissioner

Questions &Discussion

Agenda






2:15pm Adjourn

“RAPID Alliance Update and Strategies for Advancing

Work of Profession”


• 11:00am – 11:45am

The RAPID Alliance | Research to Accelerate Pharmacist/Pharmacy Innovation and Delivery of Services that Improve Health and Wellbeing| © 2020 All Rights Reserved

A Research Project of the National Science Foundation Center for Health Organization Transformation at the University of Louisville

The RAPID Alliance StudyEvidence-Based Strategies for Protecting and Improving US Population Health and Wellbeing through

US Pharmacists and Pharmacies During and After the COVID-19 Pandemic

A Conversation with

The Joint Commission of Pharmacy Practitioners

December 1, 2020

Judah Thornewill, PhD | Demetra Antimisiaris, PharmDRobert Esterhay, MD | Emmanuel Ezekekwu, PhD(c)

Agenda

• Introductions

• Background

• Findings • Needs

• Barriers

• General Strategies

• COVID-19 Strategies

• Need for “Triggering Mechanisms”

• Transformational Strategies

• Policy Alignment Considerations

• RAPID Alliance 2021 Timeline

• Implications and Discussion

Introductions

• Judah Thornewill, PhD

• Principal Investigator

• Demetra Antimisiaris, PharmD, BCGP, FASCP

• Co-Investigator

• Robert Esterhay, MD

• Co-Investigator

• Emmanuel Ezekekwu, PhD(c)

• Graduate Research Assistant

Study Background

• Emergent Patient Needs • General, COVID-19

• Are pharmacists/pharmacies an underutilized resource?

• Study Questions• Unmet patient needs

• Barriers

• Enablers

• Prioritized strategies

• Method • Implementation science framework

• Delphi technique – 4 rounds

• Virtual

• 62 leaders; balanced representation

Findings: Scope of Opportunity

One of the most significant pockets of opportunity in US healthcare

1. ~330 Million US residents 2. Billions of COVID-19 tests and

immunizations needed through 2022

3. $528B+ in excess health spending from non-optimal medication therapies

4. Pharmacist/Pharmacy driven increases in “Healthy Days • A simple population-level measure of

health and wellbeing

• Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug-Related Morbidity and Mortality. AnnPharmacother. 2018 Sep;52(9):829-837. doi: 10.1177/1060028018765159. Epub2018 Mar 26.

PMID: 29577766.

• Moriarty, D., et al. (2003). "The Centers for Disease Control and Prevention's Healthy Days Measures-Population tracking of perceived physical and mental health over time." Health and Quality of Life Outcomes 1(1): 37.

Findings: Unmet Patient Needs*

CROSS-CUTTING

1. Health data sharing

2. Social determinants

SERVICES

3. Comprehensive medication management (CMM)

4. Immunizations and prevention including COVID

5. Screening and testing including COVID

6. Chronic disease management support

7. Behavioral health and substance use disorder screening and support

8. Wellness support

PUBLIC EDUCATION

9. Health education

10. Unique role of pharmacists/pharmacies

ACCESS

11. Transportation / last mile

12. Filling primary care access gaps

* Including new emergent needs brought to light by COVID-19 Pandemic and emerging opportunities for pharmacists to act to make a difference

Findings: Barriers to Meeting Needs

1. Payment barriers

2. Policy barriers (Federal and State)

3. Health IT / Health information exchange barriers

4. Profession related barriers

5. Public awareness barriers

6. Service delivery barriers

7. Lack of collaboration across sector

8. Legacy barriers

Findings: General Strategies (2021-2025)

1. Expand offerings of valuable pharmacy services (8 strategies)

2. Policy reform to increase payments, strengthen practice (7 strategies)

3. Position pharmacists and pharmacies for the Future (4 strategies)

4. Collaborative action (12 strategies)

5. Develop Health IT / HIE platforms and services (2 strategies)

6. Strengthen and disseminate evidence of value (5 strategies)

7. Advance the profession (4 strategies)

7 Strategy Areas; 42 Strategies

Findings: COVID-19 Strategies (2021-2022)

1. Payment: All plans reimburse for pharmacy-based COVID-19 tests, vaccines, cognitive services, telepharmacy, and at-risk/low SES support

2. Policies: Federal & state policymakers support provider status; vaccine authority; increased reimbursements; reduce practice barriers

3. Health IT / Data Sharing: Strengthen pharmacy standards; support patient-access rights; support COVID-19 tech innovation

Need for Transformational Strategies An Implementation Science Perspective

Braithwaite et al (2018), when complexity science meets implementation science: a theoretical and empirical analysis of systems change.

How to Overcome Fragmentation?

The key lessons are that change can be stimulated in

many ways, but a triggering mechanism is needed, such as legislation or widespread stakeholder agreement; that feedback loops are crucial to continue change momentum; that extended sweeps of time are involved, typically much longer than believed at the outset; and that taking a systems-informed, complexity approach, having regard for existing networks and socio-technical characteristics, is beneficial.

Four Transformational Strategies

Develop Advanced Value-Driven

Pharmacy Practice Models

Develop Person-Centered, Pharmacy-

Connected Data Sharing Platforms

Develop Strategic Steering Group

Develop “Big-Tent” Research Consortia

NSF an efficient mechanism4 Overarching Goals: Healthy Days; Quadruple Aim; Growth of Service; Strengthen reputation of profession.

Work with CMMI?Pharmacists and Pharmacies get

paid

Policy Alignment Considerations

Administration Priorities*

COVID-19

Economic Recovery

Racial Equity

Climate Change

Value-Based Care

Medicaid Expansion

Strengthen Public Health Infrastructure

Person-Centered Health IT

How the US Pharmacist and Pharmacy Sector Can Help

COVID-19 Tests, Vaccines, Meds, Patient Support

Share inspiring vision: access to optimized medications therapies and

vaccines for all Americans

Develop advanced pharmacy practice models

Employ Pharmacists and Technicians

Enable pharmacy-connected data sharing platform(s)

* Biden transition website: www.buildbackbetter.com; Leavitt Partners Policy Briefing November 15, 2020

http://www.buildbackbetter.com/

RAPID Alliance 2021 Calendar (proposed)

• RAPID Alliance Press Release and Report Publication. Download report via www.rapidalliance.org website

Jan. 13, 2021, 9am ET

• RAPID Alliance Research Council Organizing Meeting #1Jan. 19, 2021, 1pm ET

• RAPID Alliance Leadership Council Organizing Meeting #1Jan. 26, 2021, 1pm ET

• RAPID Insights™ Public Webinar. Evidence-based Strategies to Protect Population Health During the COVID-19 Pandemic

Feb. 3, 2021, 1pm ET

• Project Meeting? Transformational Payment/Practice Models Research Planning Meeting #1?

Feb. 10, 2021, 1pm ET

• Project Meeting? LIFE Platform R&D Study. Kick-off Meeting?

Feb. 18, 2021, 1pm ET

http://www.rapidalliance.org/

Implications and Invitation to Collaborate

Lots of Opportunities for Change

What do we want to do next?

Open Discussion

Thank You

Lunch Break

• 11:45am –12:15pm

Agenda






2:15pm Adjourn

“GTMRx Update and How Its Work Aligns to JCPP’s Focus”


• 12:15pm – 1:00pm

©GTMR Institute, 2020 | gtmr.org

Katherine Herring Capps

Co-founder, Executive Director

GTMRx Institute

[email protected]

84

Question and Answer Session

Agenda






2:15pm Adjourn

Discussion on Strategic Framework to Advance Pharmacy Practice


• 1:00pm – 2:15pm

• Vision

• Focus Areas

• Winter meeting discussion


JCPP Vision: Patients achieve optimal health and medication outcomes with pharmacists as essential and accountable providers within patient‐centered, team-based healthcare.

• Establishing, implementing and promoting a consistent patient care process that is scalable and viable

• Pharmacist Patient Care Practice Model (May 2014)

• Understanding and recognizing the evidence that demonstrates and validates the valueof pharmacists’ patient care services

• April 8th statement by HHS on pharmacists’ contributions to COVID-19• Use of evidence in national consumer awareness campaigns (e.g., Pharmacists for Healthier Lives)• The Community Preventive Health Services Taskforce -systematic review of interventions delivered

by community and health system pharmacists for cardiovascular disease patients on July 28th.

• Integrating quality measures into pharmacy services• Pharmacy Quality Alliance

• Ensuring access to health information technology (HIT)• Pharmacy HIT Collaborative• Pharmacist e-Care Plan development and integration into IT systems

• Obtaining universal access to and coverage for pharmacists’ patient care services• Attempts in the 114th, 115th and 116th Congresses• Progress in some commercial programs and select state Medicaid programs

https://jcpp.net/wp-content/uploads/2016/03/PatientCareProcess-with-supporting-organizations.pdf

https://www.thecommunityguide.org/findings/cardiovascular-disease-tailored-pharmacy-based-interventions-improve-medication-adherence?deliveryName=USCDCCG_25-DM34032


Steps Along the Way…

Existing JCPP PlanExperiences from

COVID-19

Sustainability of Gains

New Directions

Thoughts?Current Plan

• Patient Care Process

• Value

• Quality

• HIT

• Provider Status

WHAT WERE YOUR TAKEAWAYS FROM THIS MORNING’S PRESENTATIONS AND ITS INFLUENCE ON JCPP’S PLAN?

Revised Plan Considerations

• Telehealth

• Public Health

• Mental Health of Pts and Staff and overcoming stigmas

• Equity, Diversity & Inclusion

• Value-based fee for service models

• Chronic care prevention / population health

• Fragility of pharmacy workforce (well-being, mental health, job security, career advancement, etc.)

AREAS FOR NEW PLAN FOCUS – WHAT COULD JCPP DO?• Value Proposition

• Business / Economic Case• Public recognition • Team-based / interprofessional care delivery• Provider Optimization

• Well-being• Authority / Scope


Goal Modifications Post-COVID? Temperature Check…Which to Keep / Which to Replace or Modify?

Current Post-COVID

Establishing, implementing and promoting a consistent patient care process that is scalable and viable

Understanding and recognizing the evidence that demonstrates and validates the value of pharmacists’ patient care services

Integrating quality measures into pharmacy services

Ensuring access to health information technology (HIT)

Obtaining universal access to and coverage for pharmacists’ patient care services

(MEETING LOCATION : VIRTUAL / SEPT: SHERATON SUITES OLD TOWN HOTEL

– REGISTRATION AT JCCP.NET

2021 Meeting Dates

Meeting Date

February 2, 2021 – VIRTUAL Chair: Bartlemay (ACA)https://jcpp.net/event/jcpp-february-2-2021-meeting-virtual/May 5, 2021 – VIRTUAL Chair: Maddux (ACCP)September 30, 2021 – LIVE Chair: Knoer (APhA)

https://jcpp.net/event/jcpp-february-2-2021-meeting-virtual/

February 2, 2021

• AGENDA • 8:45am – 9:45am CEO Only Meeting (via Teams, info sent separately)•• 10:00am-10:15am Agenda Item 1: Welcome and Intros•• 10:15am – 11:00am Agenda Item 2: “State of the Pharmacy Workforce” – Supply and Demand

• Perspectives - Presentation by Pharmacy Workforce Center•• 11:00am – 11:45am Agenda item 3: “Healthcare and Pharmacy Challenges and Opportunities over

• the Next Four Years”• Session coordinator / speakers?

•• 11:45am – 12:15pm Lunch Break•• 12:15pm – 2:00 pm Agenda Item 4: JCPP Direction –

• Propose 2 objectives in each bucket that JCPP and its member organizations can collectively advance over the next 5 years (2021-2025)• Value Proposition (Snead)

• Business / Economic Case• Public recognition (Maine)• Team-based / interprofessional care delivery (Maddux)• Provider Optimization (Abramowitz)

• Well-being• Authority / Scope

•• 2:00pm – 2:15pm Wrap-Up / Next steps

•• 2:15pm Adjourn

• Hot Topic DiscussionOpportunity for JCPP member organizations to raise issues that other organizations should be aware of

– Future Meeting Agenda Topics

JCPP Meeting Proposed Agenda Topics – 2021 “Year of the Future”

Timeslot MAY 5, 2021 SEPTEMBER 30, 2021

Slot 1 (10:00am –

11:00am)

Slot 2 (11:00am - noon)

Slot 3 (12:30pm –

1:30pm)

Slot 4 (1:30pm-2:15pm)

Other*

Organizational Updates• Brief discussions on activities being

undertaken that advance progress in one or more of JCPP’s Action Plan Critical Areas

• Organization Update (other information)

• Order of Updates– ACA

– ACCP

– AMCP

– APhA

– ASCP

– ASHP

– ACPE

– AACP

– CPNP

– HOPA

– NABP

– NASPA

– NCPA– other organizations

• Next meeting date:

– February 2, 2021–• Virtual

Go to jcpp.net

NEXT MEETING – VIRTUAL

FEBRUARY 2, 2021

“Year of the Future”

Documents

Transcript of “Year of the Future”